Executive Vice President & Chief Technology Officer, Biomarin Pharmaceutical
Search every verified C. Guyer interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Greg Guyer, Ph.D., joined BioMarin in May 2020 and serves as its Chief Technical Officer and Executive Vice President. In a September 2023 appearance, Guyer described the company as being "founded on just unbelievably strong science" and "on this kind of cusp of the next generation of breakthrough products." He noted that senior leaders in the organization participate directly in research and development work, including viral vector efforts, to gain intimate understanding of products from their inception. Guyer stated that this "scientific acumen" is a "critical foundational skill" that creates "seamlessness from R&D into the process development into our commercial manufacturing," which he said gives the company "a lot higher probability of success." He previously worked at the FDA and at Bristol Myers Squibb, where he said he developed an interest in new technologies.
“This company is founded on just unbelievably strong science; we are on this kind of cusp of the next generation of breakthrough products you can see it coming to life.”
“We have people that are in the top of our organization sitting in R&D actually helping with some of the viral vector work, truly understanding things at the very inception so that when that product comes through they understand it intimately well.”
“That scientific acumen is such a critical foundational skill; it really drives a seamlessness from R&D into the process development into our commercial manufacturing which gives us a lot higher probability of success.”
Greg Guyer, Ph.D, joined BioMarin in May 2020 and currently serves as our Chief Technical Officer and Executive Vice President ...
Sign in to search the full transcript archive, filter by topic, and access every quote from C. Guyer.